Subscribe Now!

Rolling Stocks Reports

From: $9.95 / month with a 7-day free trial



Rolling Stocks Report

The rolling stocks report delivers a weekly list of 10 to 12 stocks that have been in a recent rolling pattern.  The report shows the “support” and “resistance” price levels of each stock, a brief business summary and the historical graph of the underlying stock.  The rolling stocks strategy has returned an average range of 10% to 23% over the past 9 years.

Example Graph and Report

Rolling Stock Sample Report

This report is a sample only and you should not rely on the data within it.
StockCompany NameSupportResistanceOptions
DOCPhysicians Realty Trust $17.00$18.75Yes
ARDSAridis Pharmaceuticals Inc$6.00$8.00Yes
GERNGeron Corp$1.50$2.10Yes
ACETAdicet Bio Inc$12.00$16.00Yes
HTLDHeartland Express Inc$18.25$20.00Yes
SYSo-Young International Inc$11.50$16.00Yes
USEGUS Energy Corp$4.95$6.00Yes
IRMDIRadimed Corp$22.50$25.00Yes
MBIOMustang Bio Inc$2.90$4.05Yes
VEROVenus Concept Inc$2.00$2.60Yes
AGLEAeglea Bio Therapeutics Inc$7.00$8.50Yes
SPPISpectrum Pharmaceuticals Inc$3.40$5.00Yes
Sample: The data in this table is a sample only, and is not current.
Click To Expand ChartDescription
DOC DOC -Physicians Realty Trust
Support - $17.00
Resistance - $18.45

Business Summary - Physicians Realty Trust (the Trust) is a real estate investment trust. Physicians Realty L.P. is the operating partnership of the Trust. The Trust and its operating partnership are engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. As of December 31, 2016, the Company's portfolio consisted of 246 properties located in 29 states with approximately 10,883,601 net leasable square feet.
ARDSARDS -Aridis Pharmaceuticals Inc
Support - $6.00
Resistance - $8.00

Business Summary - Aridis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs), to treat infections. mAbs represents treatment approach that enables the human immune system to fight infections and are designed to overcome the deficiencies associated with current therapies, such as rise in drug resistance, short duration of response, negative impact on the human microbiome, and lack of differentiation among the treatment alternatives.
GERNGERN -Geron Corp
Support - $1.50
Resistance - $2.10

Business Summary - Geron Corporation (Geron) is a late-stage clinical biopharmaceutical company, which is focused on development and commercialization of imetelstat, a therapeutic for hematologic myeloid malignancies. The Company operates through a single segment, which is engaged in the development therapeutic products for oncology. Imetelstat is a lipid conjugated 13-mer oligonucleotide that is designed to be complementary to and bind with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity.
ACET ACET -Adicet Bio Inc
Support - $12.00
Resistance - $16.00

Business Summary - Adicet Bio Inc., formerly resTORbio, Inc., is a biotechnology company. The Company is focused on developing allogeneic gamma delta T cell therapies for cancer and other diseases. It is developing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enable selective tumor targeting, facilitate innate and adaptive anti-tumor immune response and improve persistence for durable activity in patients. Its pipeline includes ADI-001, ADI-002 and ADI-00x.
ARDSHTLD -Heartland Express Inc
Support - $18.25
Resistance - $20.00

Business Summary - Heartland Express, Inc. is a holding company. The Company is a short-to-medium haul truckload carrier. The Company focuses primarily on short- to medium-haul, asset-based dry van truckload services in regional markets near its terminals. The Company's truckload services are primarily asset-based transportation services in the dry van truckload market, and it also offers truckload temperature-controlled transportation services and non-asset based brokerage services. All tractors are equipped with mobile communication systems.
SYSY -So-Young International Inc
Support - $11.50
Resistance - $16.00

Business Summary - SO-YOUNG INTERNATIONAL INC. is a China-based holding company mainly engaged in online destination for discovering, evaluating and reserving medical aesthetic services. The Companyoperates through two segments: Information Services segment and Reservation Services segment.
USEGUSEG -US Energy Corp
Support - $4.95
Resistance - $6.00

Business Summary - U.S. Energy Corp. (U.S. Energy) is an independent energy company focused on the acquisition and development of oil and gas producing properties in the continental United States. The Company's business activities are focused on South Texas and the Williston Basin in North Dakota. The Company operates through Oil and Gas segment. The Company participates in oil and gas projects primarily as a non-operating working interest owner through exploration and development agreements with various oil and gas exploration and production companies.
IRMDIRMD -IRadimed Corp
Support - $22.50
Resistance - $25.00

Business Summary - IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment.
MBIOMBIO -Mustang Bio Inc
Support - $2.90
Resistance - $4.05

Business Summary -Mustang Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on translating medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. The Company’s pipeline is focused in three areas: gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors. MB-107 is an Ex vivo Lentiviral Therapy for X-linked Severe Combined Immunodeficiency. Its MB-102 is a CD123 CAR T cell Program for acute myeloid leukemia (AML).
VERO VERO -Venus Concept Inc
Support - $2.00
Resistance - $2.60

Business Summary - Venus Concep, Inc., formerly Restoration Robotics, Inc., develops and manufactures devices for the medical aesthetic market. The Company offers a range of products and services under various brands, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Heal, Venus Skin and Venus Bliss. It offers a product portfolio of minimally invasive and non-invasive medical aesthetic technologies in over 60 countries and 29 direct markets.
AGLEAGLE -Aeglea Bio Therapeutics Inc
Support - $7.00
Resistance - $8.50

Business Summary - Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing a human enzyme therapeutics as advanced solutions for rare and other high-burden diseases. The Company’s product candidates are Pegzilarginase, ACN00177 and AEB5100. Its Pegzilarginase is a recombinant human Arginase one that enzymatically degrades the amino acid arginine to lower arginine levels in patients with Arginase One Deficiency. Its engineered pegzilarginase with modifications that enhance the stability and arginine-degrading activity of the enzyme in human plasma.
SPPISPPI -Spectrum Pharmaceuticals Inc
Support - $3.40
Resistance - $5.00

Business Summary - Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company operates through developing and commercializing oncology and hematology drug products segment. It focuses on developing ROLONTIS and POZIOTINIB. ROLONTIS is being investigated for the treatment of chemotherapy-induced neutropenia. POZIOTINIB is an oral pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR, HER) Family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations.


Go to Top